Cargando…
Cefoperazone/sulbactam-induced hemolytic anemia
Drug-induced hemolytic anemia (DIHA) is a rare complication of drug therapy and usually underdiagnosed. Cefoperazone/sulbactam is a compound prepared from the third generation of cephalosporin and β-lactamase inhibitor. There are limited data of DIHA induced from cefoperazone/sulbactam. A 93-year-ol...
Autores principales: | Sun, XM, Liu, LH, Wu, Q, Wang, HG |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9997602/ https://www.ncbi.nlm.nih.gov/pubmed/34528516 http://dx.doi.org/10.4103/jpgm.JPGM_1335_20 |
Ejemplares similares
-
Hemolytic Anemia and Reactive Thrombocytosis Associated With Cefoperazone/Sulbactam
por: Zhou, Ling, et al.
Publicado: (2019) -
Hypersensitivity vasculitis induced by cefoperazone/sulbactam
por: Islek, Ismail, et al.
Publicado: (2003) -
Levetiracetam-induced gingival hyperplasia
por: James, J, et al.
Publicado: (2022) -
Bullous hemorrhagic dermatosis: A rare cutaneous reaction of heparin
por: Dhattarwal, N, et al.
Publicado: (2023) -
Delayed immune-mediated hepatitis after three cycles of pembrolizumab for the treatment of sinonasal melanoma
por: Kang, S, et al.
Publicado: (2023)